Infinity Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Infinity Pharmaceuticals

29/03/2022 23:28

* Infinity Pharmaceuticals Inc  INFI.OQ  reported a
quarterly
adjusted loss of 13 cents​​ per share for the quarter ended in
December. The mean expectation of eight analysts for the quarter
was for a loss of 13 cents per share.
    * Revenue rose 3.4% to $451.00 thousand from a year ago; 
analysts
expected $301.50 thousand. 
    * Infinity Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 13 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Infinity Pharmaceuticals Inc shares had fallen by 56.0%
this
quarter.
    * The company reported a quarterly loss of $11.65 million.
    * Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 29 at 10:28 p.m.  ​All
figures in US dollars unless otherwise stated